Summary
This large international genomic study identified 27 loci associated with white matter hyperintensity burden, a marker of cerebral small vessel disease, and provided evidence that genetic risk variants influence white matter integrity across the lifespan. Mendelian randomization analyses suggested causal relationships between increasing WMH volume and stroke and Alzheimer-type dementia risk, whilst also revealing blood-pressure-independent biological pathways underlying small vessel disease. The findings support genetic stratification of high-risk individuals and identification of potential drug targets for preventive intervention trials.
UK applicability
The findings are relevant to UK clinical practice and research, as cerebral small vessel disease contributes significantly to stroke and dementia burden in ageing populations. However, the study is primarily mechanistic and genomic; direct translation to UK primary or secondary prevention strategies would require prospective validation and health economic assessment in UK populations.
Key measures
WMH volume (primary outcome); white matter integrity in young adults; associations with stroke and Alzheimer-type dementia; blood pressure relationships; expression of 39 genes with 4 encoding known drug targets
Outcomes reported
The study identified 27 genome-wide loci associated with white matter hyperintensity (WMH) volume in 50,970 older individuals and examined lifetime genetic impacts on brain white matter integrity and clinical outcomes including stroke and dementia risk.
Topic tags
Dig deeper with Pulse AI.
Pulse AI has read the whole catalogue. Ask about this record, its theme, or how the findings apply to UK farming and policy — every answer cites the underlying studies.